Reliance Stock Volatile After 5% Loss, Experts Remain Bullish
Reliance Industries share price traded volatile on Jan 7 after a sharp fall. Experts see long-term growth from Jio & Retail. Read for key targets and analysis.
Category : Search result: Novo Nordisk stock price
Natco Pharma Sues to Revoke Novo Nordisk's Semaglutide Patent
Natco Pharma files suit in Delhi High Court seeking revocation of Novo Nordisk's patent on diabetes drug semaglutide. Court issues notice, hearing set for Feb 5. Indian pharma race for generic Ozempic heats up.
Why Indian Drug Makers Challenge Global Patents
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Stock Market Declines: RIL, HDFC Bank Top Losers on Jan 06
Indian stock markets fell for second straight session on January 6. Nifty closed 0.28% lower, Sensex down 0.51%. RIL and HDFC Bank were major drags. Read full analysis.
Natco Files to Revoke Novo Nordisk's Wegovy Patent in India
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Cupid Stock Jumps 11%, Snaps 2-Day Losing Streak
Small-cap multibagger Cupid surged 11% on January 6, recovering from a 35% drop. Read the latest on this volatile stock's market performance.
Novo Nordisk launches Wegovy weight-loss pill in US
Novo Nordisk launches oral Wegovy weight-loss drug in the US, priced at $299. The pill, approved in Dec 2025, aims to regain market share from rival Eli Lilly. UK approval expected end-2026.
Novo Nordisk: Wegovy Price Cut to Boost India Obesity Therapy 5-7x
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
Smallcap Stock Under Rs 300 Gains on Major Orders
Shares of a BSE-listed smallcap company surged after securing consecutive orders worth crores. Discover the stock details, financials, and future outlook for investors.
Stock Under Rs 50 Gains 297%, Hits Upper Circuit
A small-cap stock priced under Rs 50 delivered a staggering 297% return in one year, hitting the upper circuit as Indian markets rallied in early trade. Discover the details and key drivers behind this surge.
MCX Stock Adjusts After 1:5 Split, No Real Loss
MCX shares show an 80% price adjustment post 1:5 stock split. Understand the corporate action and why investor wealth remains unchanged. Read the full analysis.
ATF Price Cut in Delhi, Commercial LPG Rate Hiked
Aviation turbine fuel price reduced sharply in Delhi after three hikes. Commercial LPG cylinder price up by ₹111. Read the latest fuel price revisions and their impact.
Weight-Loss Pill Race in 2026: Lilly Leads Novo Nordisk
Novo Nordisk and Eli Lilly to launch oral GLP-1 drugs in 2026. Despite Novo's head start, analysts predict Lilly's market leadership in obesity and diabetes treatments will persist for years. Explore the details.
TCI Finance Shares Jump 144% in 10 Days, Hit Upper Circuit
TCI Finance shares surge 144.3% in ten trading sessions, hitting upper circuits repeatedly. The NBFC stock's rally defies market volatility, delivering massive returns. Read the full analysis.
Auto Stock Under Rs 50 Jumps 15% in Market Recovery
An auto ancillary stock, trading below Rs 50, surged 15% as benchmark indices bounced back. Discover the key drivers behind this rally and the stock's performance details.
Stock Markets Soar on Final Trading Day of 2025
Indian stock markets closed 2025 with strong gains. Sensex and Nifty surged, led by Tata Steel, BEL, and Adani Ports. Get the full analysis of the year-end rally and outlook.
SUV Price Hike in Jan 2026: Honda, MG, Mercedes, BMW
Planning to buy an SUV? Prices for Honda Elevate, MG Hector, Mercedes GLA, BMW X1 & others are set to rise from Jan 1, 2026. Book now to lock in current rates.
Kotak Bank Stock Split: Record Date Fixed for Jan 14
Kotak Mahindra Bank fixes January 14, 2026 as record date for its 1:5 stock split. Learn eligibility details, share price impact, and what it means for investors.
Titan Shares Reach Record High on Bullion Rally
Titan share price surged 2% to a record ₹3977, fueled by soaring gold and silver prices amid US rate cut hopes and Venezuela tensions. Do you own the stock?
Silver Price Hits Record High, Jumps 4% on MCX
Silver price today soared nearly 4% to a record high of ₹2,32,200/kg on MCX. Global spot silver also hit an all-time peak. Discover the driving factors behind this rally.
FDA Approves Daily Wegovy Pill for Weight Loss
US FDA approves Novo Nordisk's daily Wegovy pill, an oral alternative to injections. Priced from $149, it offers 14% average weight loss. Details on cost, side effects, and how it compares to rivals.
Novo Nordisk stock jumps 7% on FDA approval for Wegovy pill
Shares of Novo Nordisk surged over 7% after its weight loss drug Wegovy pill received US FDA approval on December 22, 2025. Read the full market impact analysis.
First Weight-Loss Pill Approved in US, Priced $149/Month
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
Emcure Enters Obesity Market with Novo Nordisk's Semaglutide
Emcure Pharmaceuticals launches Poviztra, a weekly semaglutide injection for weight loss, in partnership with Novo Nordisk. Priced from ₹2,200 per week, it targets India's massive obesity market.
Kalyan Jewellers Share Price Jumps 63% from 52-Week Low
Kalyan Jewellers share price surged to ₹487, up 63% from its low. Experts analyze if you should buy amid the gold rally and provide key target levels. Read for insights.
Gold Prices Fall: Check Today's Rates in Major Cities
Gold and silver prices declined on Thursday, influenced by weak global trends. Get the latest 22K and 24K gold rates for Delhi, Mumbai, Chennai, and other major Indian cities here.
Gold, Silver Price Prediction: Bullish Trend Intact, Says Expert
MCX Gold and Silver prices show strong bullish momentum. Expert Abhilash Koikkara of Nuvama sets targets of ₹137,000 for Gold and ₹210,000 for Silver. Read the full technical outlook and trading strategy.
Court Rejects Ozempic Patent Extension, Boosts Generic Drug Access
Delhi High Court rejects Novo Nordisk's patent plea on semaglutide (Ozempic/Wegovy), preventing 'evergreening'. A win for affordable generics in India, but raises concerns over non-clinical misuse of weight-loss drugs. Read more.
Delhi HC sides with Dr Reddy's in semaglutide patent case
Delhi High Court rejects Novo Nordisk's plea for interim injunction against Dr Reddy's Labs over semaglutide. Court cites 'evergreening', allows DRL to export. Key ruling for diabetes drug market.
India's Drug Patent Wars: Need for Special Courts?
A recent Delhi High Court order in the Novo Nordisk vs Dr Reddy's case highlights the complexities of Indian patent litigation. We examine the system's challenges and the push for specialized IP courts.
Page 1 of 4